Aguiar, M. and Nico Stollenwerk (2020). The Impact of Serotype Cross-Protection on Vaccine Trials: DENVax as a Case Study. Vaccines, 8, 674.
DOI: https://doi.org/10.3390/vaccines8040674

Aguiar, M., Ortuondo, E.M., Bidaurrazaga Van-Dierdonck, J. et al.(2020). Modelling COVID 19 in the Basque Country from introduction to control measure response. Nature Sci. Rep. 10, 17306.
DOI:https://doi.org/10.1038/s41598-020-74386-1

Aguiar, M., Stollenwerk, N. (2020). Condition-specific mortality risk can explain differences in COVID-19 case fatality ratios around the globe. Public Health, 188, 18–20.
DOI:https://doi.org/10.1016/j.puhe.2020.08.021

Aguiar M., Van-Dierdonck J.B., Stollenwerk N. (2020). Reproduction ratio and growth rates: Measures for an unfolding pandemic. PLoS ONE 15(7): e0236620.
DOI:https://doi.org/10.1371/journal.pone.0236620

Maíra Aguiar and Nico Stollenwerk. (2020). SHAR and effective SIR models: from dengue fever toy models to a COVID-19 fully parametrized SHARUCD framework. Commun. BioMath. Sci., 3(1): 60-89.
DOI:https://doi.org/10.5614/cbms.2020.3.1.6

Scott B. Halstead, Leah C. Katzelnick, Philip K. Russell, Lewis Markoff,  Maíra Aguiar, Leonila R. Dans, Antonio L. Dans. (2020). Vaccine, 38(35): 5572–5576.
DOI:https://doi.org/10.1016/j.vaccine.2020.06.079

P. Rashkov, E. Venturino, M. Aguiar, N. Stollenwerk and B. W. Kooi. (2019). On the role of vector modeling in a minimalistic epidemic model. Mathematical Biosciences and Engineering,6(5): 4314-4338.
DOI:https://doi.org/10.3934/mbe.2019215

Close Menu